[
    {
        "pregunta": "1. Under what conditions does the guideline suggest delaying TJA to improve glycemic control?",
        "respuesta": "La guía sugiere condicionalmente **retrasar la artroplastia total de rodilla (ATR)** en pacientes definidos con **diabetes mellitus mal controlada**, con el fin de mejorar el control glucémico antes de proceder con la cirugía. Esta recomendación es de base en evidencia de **muy baja certeza**.",
        "contexto": [
            "| In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. | Very low                 |\n| In our defined population with nicotine dependence, we conditionally recommend delaying arthroplasty for nicotine use reduction/cessation. | Low                       |",
            "to achieve weight reduction to a BMI of <35. Very low 9 77-130 In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low 10 131-156 In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Low 11 157-180 In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to",
            "use of ambulatory aids such as canes, as improper use may lead to altered gait mechanics, increased pain, and worsened function In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of intraarticular glucocorticoid injections. This recommendation is conditional because there may be exceptions to this recommendation, and the evidence supporting the recommendation is indirect and very low quality. The exceptions listed",
            "aids. Very low 4 47-53 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of intraarticular glucocorticoid injections. Very low 5 54-63 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections. Very low 6 64-76 In our defined population with a BMI of ≥50, we conditionally recommend proceeding to TJA without",
            "|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of intraarticular glucocorticoid injections.|Very low|5|54–63|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections.|Very low|6|64–76|"
        ]
    },
    {
        "pregunta": "2. How is radiographic severity of osteoarthritis or osteonecrosis assessed when considering TJA?",
        "respuesta": "La gravedad radiográfica de la osteoartritis (OA) o la osteonecrosis (ON) al considerar una artroplastia total de rodilla (ATR) se evalúa utilizando sistemas de clasificación estándar como la escala de Kellgren-Lawrence para OA o la escala de Tönnis para ON. Estos sistemas valoran la severidad mediante imágenes radiográficas y permiten categorizar la enfermedad en grados moderados a severos para tomar decisiones sobre el tratamiento quirúrgico.",
        "contexto": [
            "There were no studies that either directly or indirectly answered our PICO question. 13 181 * The defined population is patients with radiographically moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee using standard radiographic grading such as Kellgren/Lawrence or Tonnis, and for patients with moderate-to-severe pain or loss of function who have been indicated for elective total joint arthroplasty (TJA) through a shared decision-making process with their physician and have",
            "<li>The defined population is patients with radiographically moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee using standard radiographic grading such as Kellgren/Lawrence or Tonnis, and for patients with moderate-to-severe pain or loss of function who have been indicated for elective total joint arthroplasty (TJA) through a shared decision-making process with their physician and have completed trials of ≥1 appropriate nonoperative therapy. BMI = body mass index; NSAIDs =",
            "consists of patients who have moderate-to-severe pain and loss of function and moderate-to-severe radiographic OA or ON with secondary arthritis, using standard radiographic measures such as Kellgren/Lawrence (K/L) grade Patients who have certain risk factors, such as obesity, diabetes mellitus, and nicotine use, may also have surgical treatment delayed by hospital policy or third-party payers in order to meet specific criteria to mitigate their surgical risk. However, while these factors are",
            "loss, or in patients with a neuropathic joint. Recommendation for patients with radiographically moderate to severe OA or ON of the hip or knee using standard radiographic grading such as Kellgren-Lawrence or Tonnis, and moderate to severe pain or loss of function who have been indicated for elective TJA through a shared decision-making process with their physician and have completed one or more trials of appropriate nonoperative therapy Certainty of Evidence In our defined population, we",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |"
        ]
    },
    {
        "pregunta": "3. What level of certainty of evidence underpins the recommendations about proceeding to TJA without delay?",
        "respuesta": "The level of certainty of evidence supporting the recommendation to proceed to total joint arthroplasty (TJA) without delay is **very low**. The guideline conditionally recommends proceeding without delay over delaying arthroplasty for three months, but this recommendation is based on very low-quality evidence.",
        "contexto": [
            "<p>|Recommendation|Certainty of evidence|Based on the evidence report|Page numbers of evidence tables in the Supplementary Appendix†|\n|---|---|---|---|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months.|Very low|1|1–7|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy.|Low|2|8–37|",
            "<p>| <strong>Recommendation</strong>                                                                                                 | <strong>Certainty of Evidence</strong> |\n|---------------------------------------------------------------------------------------------------------------------|---------------------------|\n| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. | Very low                 |",
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs",
            "recommendations in this guideline are conditional due to the low or very low quality of evidence (Table 1 In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months. There should be no mandate that patients wait 3 months prior to TJA as an arbitrary cool-down period. The recommendation is conditional because there may be exceptions, and the evidence supporting the recommendation is indirect and very low quality. Prior to presenting",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |"
        ]
    },
    {
        "pregunta": "4. Is obesity alone considered a valid reason to delay total joint arthroplasty according to the guideline?",
        "respuesta": "Según la guía, **la obesidad por sí sola no es una razón válida para retrasar la artroplastia total**. No se recomienda un objetivo inflexible de peso o índice de masa corporal (IMC) para realizar la cirugía, aunque se debe fomentar firmemente la pérdida de peso.",
        "contexto": [
            "or reduction. c. Delay TJA to improve glycemic control in patients with diabetes mellitus, but we do not recommend a specific measure or threshold based on our literature review. d. Obesity by itself is not a reason for delaying surgery. There should be no inflexible weight or BMI target requirement for surgery, but weight loss should be strongly encouraged. e. Do not delay surgery in patients with severe deformity, bone loss, or in patients with a neuropathic joint. Recommendation for patients",
            "| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections. | Very low                 |\n| In our defined population with body mass index (BMI) &gt; 50, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI &lt; 50. | Very low                 |",
            "injections. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections. Very low In our defined population with body mass index (BMI) > 50, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI < 50. Very low In our defined population with body mass index (BMI) 40 -49, we conditionally recommend proceeding to surgery without delay to",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "40 -49, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI < 40. Very low In our defined population with body mass index (BMI) 35 -39, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI < 35. Very low In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low In our defined population with nicotine dependence, we"
        ]
    },
    {
        "pregunta": "5. How does the guideline recommend managing elective TJA timing in patients who have attempted but failed nonoperative treatments such as physical therapy?",
        "respuesta": "La guía recomienda condicionalmente **proceder a la artroplastia total electiva sin retrasos** en pacientes con osteoartritis o osteonecrosis sintomática moderada a severa que han intentado pero no han tenido éxito con tratamientos no quirúrgicos como la fisioterapia, AINEs, ortesis o dispositivos de asistencia para la marcha, así como inyecciones intraarticulares. \n\nSe desaconseja retrasar la cirugía para un período adicional de tratamiento no quirúrgico, ya que no mejora los resultados posquirúrgicos y puede aumentar la dificultad técnica del procedimiento. Esta recomendación se fundamenta en evidencia de calidad muy baja y está basada en un proceso de toma de decisiones compartida entre el paciente y el médico.",
        "contexto": [
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "work or family obligations) or ongoing medical comorbidities that can be optimized prior to surgery. In these cases, patients may consider proceeding with nonoperative treatment (excluding intraarticular injections in some cases; see below) to provide pain relief while awaiting surgery. In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. In patients who are indicated for TJA, mandated physical therapy",
            "Arthroplasty This guideline has several strengths. The recommendations were made and voted on by a multidisciplinary collaboration group of orthopedic surgeons, rheumatologists, and patients who have undergone or are scheduled to undergo elective TJA who provided their expertise and insights. In addition, the GRADE methodology is well validated and was utilized to make these consensus-based recommendations In conclusion, this guideline provides evidence-based recommendations regarding the",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "of bias, imprecision, as well as indirectness. No recommendations were supported by high or moderate quality evidence. There are many existing appropriateness criteria, insurance coverage determination policies, and other guidelines that comment on the indications for elective TJA The Voting Panel recommended against delaying TJA in our defined population for additional nonoperative treatment including physical therapy, NSAIDs, braces or ambulatory aids, as well as intraarticular injections."
        ]
    },
    {
        "pregunta": "6. What are the limitations of the evidence quality cited in this guideline, and how does this affect the strength of the recommendations?",
        "respuesta": "Las limitaciones de la calidad de la evidencia citada en esta guía incluyen principalmente:\n\n- La **baja certeza** o calidad muy baja de la mayoría de los estudios disponibles, muchos de los cuales son de pequeña escala u observacionales.  \n- La evidencia en varios casos es **indirecta**, es decir, las poblaciones o intervenciones estudiadas no corresponden exactamente a las planteadas en las preguntas clínicas específicas de la guía.  \n- **Falta de estudios bien diseñados y controlados**, especialmente ensayos clínicos aleatorizados que permitan realizar comparaciones directas y sólidas entre tratamientos o intervenciones.  \n- Limitaciones metodológicas y heterogeneidad en las muestras, diseño de estudios y resultados evaluados.  \n- Ausencia o escasez de datos sobre resultados a largo plazo o en subgrupos específicos.\n\nEstas limitaciones afectan la solidez de las recomendaciones al hacer que muchas de ellas sean **condicionales** y fundamentadas en evidencia de baja o muy baja calidad. Por lo tanto, existe una **incertidumbre considerable sobre el efecto estimado de las intervenciones**, y las recomendaciones pueden cambiar a medida que se disponga de nueva evidencia. La guía enfatiza la necesidad de aplicar estas recomendaciones en un marco de toma de decisiones compartidas y personalizadas, considerando las circunstancias clínicas individuales y la preferencia del paciente.",
        "contexto": [
            "of moderate-or high-quality rating of the evidence, and a conditional recommendation in the presence of very-low or low-quality evidence (although recommendations can also be conditional in the setting of moderate-quality evidence, and in certain circumstances strong in the face of low-quality evidence) Limitations of the guideline include the limited comparative evidence to inform selection of therapies (i.e., primary comparative benefit/efficacy and harms evidence) and the inability to",
            "and prefer collaboration and communication among their specialists. These guidelines are limited by the low certainty of evidence available for review. Most of the questions addressed were supported by small-scale observational studies. In some cases, the evidence was indirect, indicating that the populations and/or interventions investigated in the included studies deviated from those intended for specific questions. Additionally, we did not have any available evidence to examine the",
            "to these recommendations, such as a delay for personal reasons due to family or work obligations. It is important that these unique circumstances be considered during the shared decision-making process. The major potential limitation to this guideline is the indirectness and low quality of the available evidence. Moderate-and high-quality studies addressing these PICO questions will be challenging to perform. Direct evidence for our questions would entail randomizing patients indicated for TJA",
            "on our confidence in the estimate of effect and is likely to change the estimate.” Very low quality means that “we are very uncertain about the estimate.” In the systematic review for this guideline, a judgment of moderate quality required at least some evidence from randomized controlled trials, and a judgment of low quality required at least some evidence from well‐designed observational studies with appropriate comparator groups.</p>",
            "https:// onlinelibrary.wiley.com/doi/10.1002/acr.25117 https://onlinelibrary.wiley.com/doi/10.1002/acr. 25117 The Literature Review Team performed a systematic literature review for all PICO questions, extracted relevant study data, graded the quality of evidence (high, moderate, low, very low), and produced the evidence report (see Supplementary Appendix 3, https://onlinelibrary.wiley.com/doi/10.1002/acr.25117 Guiding principles Nine guiding principles (Table 2 RESULTS/RECOMMENDATIONS Exercise"
        ]
    },
    {
        "pregunta": "7. Should intra-articular glucocorticoid injections be tried before proceeding to TJA according to the guideline?",
        "respuesta": "Según la información disponible en la guía, no se recomienda retrasar la artroplastia total para realizar un intento previo de inyecciones intraarticulares de glucocorticoides. De hecho, se recomienda de manera condicional **proceder a la artroplastia total sin retrasos** en pacientes con osteoartritis o osteonecrosis sintomática moderada a severa, incluso después de haber intentado tratamientos no quirúrgicos como inyecciones intraarticulares.\n\nPor lo tanto, la guía no sugiere hacer un ensayo adicional de inyecciones intraarticulares de glucocorticoides antes de realizar una artroplastia total; en cambio, prioriza proceder a la cirugía cuando está indicada, sin demoras adicionales para tratamientos no quirúrgicos.",
        "contexto": [
            "|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of intraarticular glucocorticoid injections.|Very low|5|54–63|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections.|Very low|6|64–76|",
            "the relative merits of different NSAIDs, there is evidence suggesting that certain agents may have more favorable side effect profiles than others Intraarticular glucocorticoid injections are strongly recommended for patients with knee and/or hip OA and conditionally recommended for patients with hand OA. Trials of intraarticular glucocorticoid injections have demonstrated short-term efficacy in knee OA. Intraarticular glucocorticoid injection is conditionally, rather than strongly, recommended",
            "injection to provide immediate pain relief. There are, however, potential harms associated with delaying surgery for glucocorticoid injection treatment, particularly in patients with diabetes mellitus who have an increased risk of hyperglycemia with intraarticular glucocorticoids or the increased risk of joint infection if the surgery is performed within 3 months of the intraarticular injection In our defined population, we conditionally recommend proceeding to TJA without delay over delaying",
            "ultrasound guidance for steroid injection may help ensure accurate drug delivery into the joint, but is not required for knee and hand joints. However, imaging guidance for injection into hip joints is strongly recommended. Intraarticular glucocorticoid injections versus other injections are conditionally recommended for patients with knee, hip, and/or hand OA. In OA generally, intraarticular glucocorticoid injection is conditionally recommended over other forms of intraarticular injection,",
            "|IAGCs are conditionally recommended as part of initial therapy.|Very low|PICO 12. In children with JIA with active TMJ arthritis, should adding intraarticular glucocorticoids to initial therapy be recommended?|53–57|\n|There is no preferred agent.|Very low|PICO 14. In children with JIA with active TMJ arthritis, should a specific steroid type be recommended for intraarticular injection?|58|"
        ]
    },
    {
        "pregunta": "8. What role does shared decision-making play in determining the timing of elective TJA according to these guidelines?",
        "respuesta": "Según la información proporcionada en la guía, la toma de decisiones compartida (shared decision-making) juega un papel central en determinar el momento óptimo para la artroplastia total electiva (TJA). Esta decisión debe basarse en una conversación exhaustiva entre el paciente y el médico que considere:\n\n- Las metas, preferencias y tolerancia al riesgo individuales del paciente.  \n- El apoyo social, el estatus socioeconómico, las comorbilidades médicas y psiquiátricas, y la gravedad de la enfermedad.  \n- Los riesgos y beneficios particulares de proceder o retrasar la cirugía.  \n\nLa guía enfatiza que cada paciente es único y que la decisión sobre si y cuándo realizar la TJA debe personalizarse en función de esta colaboración, reconociendo la considerable incertidumbre en la evidencia disponible. Por ello, las recomendaciones son condicionales y se deben aplicar en el marco de este proceso compartido, respetando las circunstancias y preferencias individuales.",
        "contexto": [
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "of the shared decisionmaking process when indicating a patient for TJA. Each patient is unique in terms of their goals, preferences, risk tolerance, social support, socioeconomic status, medical and psychiatric comorbidities, and disease severity. It should be left to the shared decision-making process for the patient and their physician to determine whether and when to proceed with TJA. This shared decision-making process should comprehensively include a discussion of the unique risks and",
            "Arthroplasty This guideline has several strengths. The recommendations were made and voted on by a multidisciplinary collaboration group of orthopedic surgeons, rheumatologists, and patients who have undergone or are scheduled to undergo elective TJA who provided their expertise and insights. In addition, the GRADE methodology is well validated and was utilized to make these consensus-based recommendations In conclusion, this guideline provides evidence-based recommendations regarding the",
            "guideline does not address arthroplasty for patients who have rheumatic diseases, as they were the focus of the recent ACR/AAHKS guideline for the perioperative management of antirheumatic medications in patients undergoing total hip and total knee arthroplasty A conditional recommendation means that the panel has inferred that the majority of informed patients would choose the recommended course of action, but that an appreciable minority would not. A shared decision-making process with full",
            "recommendations for the optimal timing of TJA in patients with symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative therapy has been ineffective and who elected to undergo TJA, and to evaluate benefits of delays of surgery for additional nonoperative arthritis treatments or to achieve specific targets for medical optimization. This guideline is intended for use during a shared decision-making process with this defined group of patients and"
        ]
    },
    {
        "pregunta": "9. What is the guideline’s stance on delaying TJA for a trial of physical therapy in patients already indicated for surgery?",
        "respuesta": "La guía **recomienda de forma condicional proceder a la artroplastia total sin retrasos** en pacientes con osteoartritis u osteonecrosis sintomática moderada a severa que ya tienen indicación para cirugía, incluso si han intentado previamente tratamientos no quirúrgicos como la fisioterapia. \n\nEspecíficamente, se desaconseja retrasar la cirugía para realizar un ensayo adicional de fisioterapia, ya que no se ha demostrado que demorar la artroplastia para un periodo adicional de tratamiento no quirúrgico mejore los resultados posquirúrgicos. Esta recomendación se basa en evidencia de **baja a muy baja certeza** y enfatiza la importancia de una toma de decisiones compartida entre paciente y médico.",
        "contexto": [
            "for our questions would entail randomizing patients indicated for TJA to receive surgical treatment or delay for a trial of additional nonsurgical treatment such as physical therapy, intraarticular injections, or bracing, and then assessing long-term patient-important outcomes. Patients and surgeons may have concerns about participating in studies in which patients could be randomized to delayed surgery or not being offered resources for risk factor modification such as poor glycemic control.",
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs",
            "<p>|Recommendation|Certainty of evidence|Based on the evidence report|Page numbers of evidence tables in the Supplementary Appendix†|\n|---|---|---|---|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months.|Very low|1|1–7|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy.|Low|2|8–37|",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "work or family obligations) or ongoing medical comorbidities that can be optimized prior to surgery. In these cases, patients may consider proceeding with nonoperative treatment (excluding intraarticular injections in some cases; see below) to provide pain relief while awaiting surgery. In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. In patients who are indicated for TJA, mandated physical therapy"
        ]
    },
    {
        "pregunta": "10. What are the potential harms of delaying TJA to achieve rigid preoperative optimization targets?",
        "respuesta": "Los posibles daños o efectos adversos de retrasar la artroplastia total de articulación (TJA) para cumplir con objetivos rígidos de optimización preoperatoria incluyen:\n\n- **Aumento de la inestabilidad articular**, lo que puede complicar el procedimiento quirúrgico.  \n- **Pérdida ósea yuxtaarticular y deformidad progresiva**, lo que incrementa la dificultad técnica de la cirugía.  \n- **Mayor riesgo de fracaso de la prótesis y necesidad de revisiones quirúrgicas posteriores**, con una tendencia a aumentar con el tiempo y la demora en la cirugía.  \n- **Incremento del dolor y pérdida de función** debido al progreso de la enfermedad durante el retraso.  \n- **Empeoramiento de comorbilidades médicas asociadas** consecuencia de la limitación en la movilidad.\n\nPor tanto, retrasar la TJA en pacientes indicados puede llevar a peores resultados tanto quirúrgicos como funcionales, y la guía recomienda condicionalmente proceder a la cirugía sin demoras para optimizar estos aspectos.",
        "contexto": [
            "In these patients, delaying TJA may lead to increased instability and increased juxtaarticular bone loss or deformity, which may increase the technical difficulty of the procedure as well as increase the risk of failure and need for revision. Although patients who have severe bone loss, deformity, or instability have an increased risk of revision or reoperation, this risk will likely only increase over time, with further delay in surgery. Thus, timely TJA should be performed in these cases when",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "the recommendation is indirect and very low quality. Prior to presenting to an orthopedic surgeon and being indicated for TJA, patients in the defined population have already attempted nonoperative treatment for an extended period. Further delay to TJA may lead to increased pain, loss of function, and worsening of medical comorbidities due to limited mobility. Patients may elect to delay surgery due to personal reasons (e.g., work or family obligations) or ongoing medical comorbidities that can",
            "|In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|12|181|",
            "for our questions would entail randomizing patients indicated for TJA to receive surgical treatment or delay for a trial of additional nonsurgical treatment such as physical therapy, intraarticular injections, or bracing, and then assessing long-term patient-important outcomes. Patients and surgeons may have concerns about participating in studies in which patients could be randomized to delayed surgery or not being offered resources for risk factor modification such as poor glycemic control."
        ]
    },
    {
        "pregunta": "11. What are the limitations of the evidence quality supporting these clinical practice recommendations?",
        "respuesta": "Las limitaciones de la calidad de la evidencia que respaldan estas recomendaciones de práctica clínica incluyen:\n\n- La mayoría de los estudios disponibles tienen **calidad muy baja o baja certeza**, incluyendo muchos estudios de pequeña escala u observacionales.  \n- Existe evidencia **indirecta**, es decir, poblaciones o intervenciones que no corresponden exactamente a las preguntas clínicas planteadas en la guía.  \n- Hay una **falta de estudios bien diseñados y controlados**, particularmente ensayos clínicos aleatorizados que permitan comparaciones directas y sólidas entre intervenciones.  \n- Las limitaciones metodológicas incluyen heterogeneidad en muestras, diseño y resultados evaluados.  \n- Escasez o ausencia de datos sobre resultados a largo plazo o en subgrupos específicos de pacientes.  \n- En ausencia de evidencia publicada, se recurrió a la experiencia clínica de los panelistas, considerada como evidencia de muy baja calidad.  \n\nEstas limitaciones explican que muchas recomendaciones sean condicionales y basadas en evidencia de baja calidad, generando considerable incertidumbre en la estimación de los efectos de las intervenciones y la necesidad de realizar decisiones personalizadas y compartidas con el paciente.",
        "contexto": [
            "of moderate-or high-quality rating of the evidence, and a conditional recommendation in the presence of very-low or low-quality evidence (although recommendations can also be conditional in the setting of moderate-quality evidence, and in certain circumstances strong in the face of low-quality evidence) Limitations of the guideline include the limited comparative evidence to inform selection of therapies (i.e., primary comparative benefit/efficacy and harms evidence) and the inability to",
            "to these recommendations, such as a delay for personal reasons due to family or work obligations. It is important that these unique circumstances be considered during the shared decision-making process. The major potential limitation to this guideline is the indirectness and low quality of the available evidence. Moderate-and high-quality studies addressing these PICO questions will be challenging to perform. Direct evidence for our questions would entail randomizing patients indicated for TJA",
            "<p>†When there were no published studies, we relied on the clinical experience of the panelists, which was designated very-low-quality evidence.</p>",
            "and prefer collaboration and communication among their specialists. These guidelines are limited by the low certainty of evidence available for review. Most of the questions addressed were supported by small-scale observational studies. In some cases, the evidence was indirect, indicating that the populations and/or interventions investigated in the included studies deviated from those intended for specific questions. Additionally, we did not have any available evidence to examine the",
            "<p>† When there were no published studies, we relied on the clinical experience of the panelists, which was designated very-low-quality evidence.</p>"
        ]
    },
    {
        "pregunta": "12. Does the guideline recommend any specific BMI targets as mandatory before proceeding with TJA?",
        "respuesta": "La guía **no recomienda un objetivo específico de índice de masa corporal (IMC) como requisito obligatorio antes de proceder con una artroplastia total de articulación (TJA)**. \n\nAunque se fomenta de manera firme la pérdida de peso en pacientes obesos, la recomendación es condicional para **proceder a la cirugía sin retrasos incluso en pacientes con IMC elevado**, y no se establecen metas rígidas de peso o IMC para realizar la artroplastia.\n\nEn resumen, el IMC por sí solo **no es una razón válida para retrasar la TJA** según la guía.",
        "contexto": [
            "through a shared decision-making process with their physician and have completed trials of ≥1 appropriate nonoperative therapy. BMI = body mass index; NSAIDs = nonsteroidal antiinflammatory drugs; PICO = population, intervention, comparator, outcomes. † In Supplementary Appendix 3, available at http://onlinelibrary.wiley.com/doi/10.1002/acr.25175 arthroplasty as a form of prerehabilitation to improve the outcome of surgery In our defined population, we conditionally recommend proceeding to TJA",
            "| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of viscosupplementation injections. | Very low                 |\n| In our defined population with body mass index (BMI) &gt; 50, we conditionally recommend proceeding to surgery without delay to achieve weight reduction to BMI &lt; 50. | Very low                 |",
            "with a BMI of 35-39, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <35. Recommendations 7-9 are conditional because there may be exceptions to these recommendations, and the evidence supporting a preoperative weight reduction and a rigid BMI or weight threshold is indirect and very low quality. A majority of the studies supporting all 3 recommendations were based on comparing TJA outcomes in patients who underwent bariatric surgical",
            "may place an unnecessary burden on the patient, with limited benefit on pain and function In our defined population with a BMI of ≥50, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <50. In our defined population with a BMI of 40-49, we conditionally recommend proceeding to TJA without delaying to achieve weight reduction to a BMI of <40. In our defined population with a BMI of 35-39, we conditionally recommend proceeding to TJA without",
            "to achieve weight reduction to a BMI of <35. Very low 9 77-130 In our defined population with poorly controlled diabetes mellitus, we conditionally recommend delaying TJA to improve glycemic control. Very low 10 131-156 In our defined population with nicotine dependence, we conditionally recommend delaying TJA for nicotine use reduction/cessation. Low 11 157-180 In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to"
        ]
    },
    {
        "pregunta": "13. Why is shared decision-making emphasized in determining the timing of TJA?",
        "respuesta": "Se enfatiza la toma de decisiones compartida en la determinación del momento para realizar una artroplastia total de articulación (TJA) porque cada paciente es único en cuanto a sus metas, preferencias, tolerancia al riesgo, apoyo social, estatus socioeconómico, comorbilidades médicas y psiquiátricas, y gravedad de la enfermedad. La guía reconoce la considerable incertidumbre en la evidencia disponible, por lo que la decisión sobre si y cuándo proceder con la cirugía debe personalizarse mediante un diálogo exhaustivo entre el paciente y su médico. Este proceso debe incluir una discusión detallada de los riesgos y beneficios particulares de proceder o retrasar la cirugía, garantizando que la decisión refleje las circunstancias y valores individuales del paciente.",
        "contexto": [
            "of the shared decisionmaking process when indicating a patient for TJA. Each patient is unique in terms of their goals, preferences, risk tolerance, social support, socioeconomic status, medical and psychiatric comorbidities, and disease severity. It should be left to the shared decision-making process for the patient and their physician to determine whether and when to proceed with TJA. This shared decision-making process should comprehensively include a discussion of the unique risks and",
            "criteria) As noted, TJA is the only approved definitive therapy for moderate-to-severe symptomatic OA of the hip or knee, yet racial disparities in arthroplasty utilization have persisted for decades The Patient Panel was instrumental in the development of this guideline and provided valuable insight into how best to apply these recommendations in the clinical setting. In particular, the Patient Panel stressed the importance of the shared decisionmaking process when indicating a patient for",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are",
            "Arthroplasty This guideline has several strengths. The recommendations were made and voted on by a multidisciplinary collaboration group of orthopedic surgeons, rheumatologists, and patients who have undergone or are scheduled to undergo elective TJA who provided their expertise and insights. In addition, the GRADE methodology is well validated and was utilized to make these consensus-based recommendations In conclusion, this guideline provides evidence-based recommendations regarding the",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo"
        ]
    },
    {
        "pregunta": "14. What are the potential risks of delaying TJA for nonoperative treatments in patients with moderate-to-severe OA or ON?",
        "respuesta": "Los posibles riesgos de retrasar la artroplastia total de articulación (TJA) para tratamientos no quirúrgicos en pacientes con osteoartritis u osteonecrosis moderada a severa incluyen:\n\n- Aumento de la inestabilidad articular, lo que puede complicar el procedimiento quirúrgico.\n- Pérdida ósea yuxtaarticular y deformidad progresiva, incrementando la dificultad técnica de la cirugía.\n- Mayor riesgo de fracaso de la prótesis y necesidad de revisiones quirúrgicas posteriores, riesgo que tiende a aumentar con el tiempo y la demora en la cirugía.\n- Incremento del dolor y pérdida de función debido a la progresión de la enfermedad durante el retraso.\n- Empeoramiento de comorbilidades médicas asociadas, secundarias a la limitación en la movilidad.\n\nPor estas razones, la guía recomienda condicionalmente proceder a la TJA sin demoras para evitar estos efectos adversos y obtener mejores resultados quirúrgicos y funcionales.",
        "contexto": [
            "In these patients, delaying TJA may lead to increased instability and increased juxtaarticular bone loss or deformity, which may increase the technical difficulty of the procedure as well as increase the risk of failure and need for revision. Although patients who have severe bone loss, deformity, or instability have an increased risk of revision or reoperation, this risk will likely only increase over time, with further delay in surgery. Thus, timely TJA should be performed in these cases when",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "the recommendation is indirect and very low quality. Prior to presenting to an orthopedic surgeon and being indicated for TJA, patients in the defined population have already attempted nonoperative treatment for an extended period. Further delay to TJA may lead to increased pain, loss of function, and worsening of medical comorbidities due to limited mobility. Patients may elect to delay surgery due to personal reasons (e.g., work or family obligations) or ongoing medical comorbidities that can",
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs"
        ]
    },
    {
        "pregunta": "15. What are the potential consequences of delaying TJA in patients with bone loss, deformity, or severe ligamentous instability?",
        "respuesta": "Las posibles consecuencias de retrasar la artroplastia total de articulación (TJA) en pacientes con pérdida ósea, deformidad o inestabilidad ligamentosa severa incluyen:\n\n- Aumento de la inestabilidad articular, lo que puede complicar el procedimiento quirúrgico.  \n- Pérdida ósea yuxtaarticular y deformidad progresiva, incrementando la dificultad técnica de la cirugía.  \n- Mayor riesgo de fracaso de la prótesis y necesidad de revisiones quirúrgicas posteriores, un riesgo que tiende a aumentar con el tiempo con el retraso en la cirugía.  \n\nPor estas razones, la guía recomienda de forma condicional proceder a la TJA sin retrasos en estos pacientes, ya que demorar la cirugía no mejora los resultados posquirúrgicos y aumenta la complejidad técnica del procedimiento.",
        "contexto": [
            "In these patients, delaying TJA may lead to increased instability and increased juxtaarticular bone loss or deformity, which may increase the technical difficulty of the procedure as well as increase the risk of failure and need for revision. Although patients who have severe bone loss, deformity, or instability have an increased risk of revision or reoperation, this risk will likely only increase over time, with further delay in surgery. Thus, timely TJA should be performed in these cases when",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "|In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|12|181|",
            "for our questions would entail randomizing patients indicated for TJA to receive surgical treatment or delay for a trial of additional nonsurgical treatment such as physical therapy, intraarticular injections, or bracing, and then assessing long-term patient-important outcomes. Patients and surgeons may have concerns about participating in studies in which patients could be randomized to delayed surgery or not being offered resources for risk factor modification such as poor glycemic control.",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo"
        ]
    },
    {
        "pregunta": "16. How does the guideline incorporate cost-effectiveness considerations in its recommendations for delaying or proceeding with TJA?",
        "respuesta": "La información proporcionada **no incluye detalles específicos sobre cómo la guía incorpora consideraciones de costo-efectividad** en sus recomendaciones acerca de retrasar o proceder con la artroplastia total de articulación (TJA). Por lo tanto, no es posible ofrecer una respuesta confiable sobre este aspecto basado en los datos disponibles.",
        "contexto": [
            "Arthroplasty This guideline has several strengths. The recommendations were made and voted on by a multidisciplinary collaboration group of orthopedic surgeons, rheumatologists, and patients who have undergone or are scheduled to undergo elective TJA who provided their expertise and insights. In addition, the GRADE methodology is well validated and was utilized to make these consensus-based recommendations In conclusion, this guideline provides evidence-based recommendations regarding the",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "of bias, imprecision, as well as indirectness. No recommendations were supported by high or moderate quality evidence. There are many existing appropriateness criteria, insurance coverage determination policies, and other guidelines that comment on the indications for elective TJA The Voting Panel recommended against delaying TJA in our defined population for additional nonoperative treatment including physical therapy, NSAIDs, braces or ambulatory aids, as well as intraarticular injections.",
            "<p>|Recommendation|Certainty of evidence|Based on the evidence report|Page numbers of evidence tables in the Supplementary Appendix†|\n|---|---|---|---|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months.|Very low|1|1–7|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy.|Low|2|8–37|",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are"
        ]
    },
    {
        "pregunta": "17. Why does the guideline conditionally recommend proceeding to TJA without delaying for trials of braces or ambulatory aids?",
        "respuesta": "La guía recomienda condicionalmente proceder a la artroplastia total de articulación (TJA) sin retrasos para realizar ensayos adicionales con órtesis o dispositivos de asistencia para la marcha porque retrasar la cirugía para este tipo de tratamientos no quirúrgicos no mejora los resultados posquirúrgicos y puede aumentar la dificultad técnica del procedimiento. Aunque el uso de ayudas para la marcha debe ser adecuado para evitar alteraciones biomecánicas que empeoren el dolor o la función, la evidencia es de baja a muy baja certeza y no respalda demorar la cirugía para prolongar estos intentos. Por ello, se prioriza avanzar con la cirugía cuando está indicada en pacientes con osteoartritis u osteonecrosis sintomática moderada a severa, tras fracaso o no tolerancia a tratamientos no quirúrgicos previos, incluyendo órtesis o dispositivos de asistencia.",
        "contexto": [
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "use of ambulatory aids such as canes, as improper use may lead to altered gait mechanics, increased pain, and worsened function In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of intraarticular glucocorticoid injections. This recommendation is conditional because there may be exceptions to this recommendation, and the evidence supporting the recommendation is indirect and very low quality. The exceptions listed",
            "|In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|12|181|",
            "nonoperative therapy Certainty of Evidence In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. Very low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy. Low In our defined population, we conditionally recommend proceeding to TJA without delay over delaying surgical treatment for a trial of nonsteroidal antiinflammatory drugs",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo"
        ]
    },
    {
        "pregunta": "18. What limitations in current evidence make it difficult to establish firm recommendations on timing of TJA?",
        "respuesta": "Las limitaciones de la evidencia actual que dificultan establecer recomendaciones firmes sobre el momento para realizar una artroplastia total de articulación (TJA) incluyen:\n\n- Calidad muy baja o baja certeza de la mayoría de los estudios disponibles.  \n- Muchos estudios son de pequeña escala, observacionales o con limitaciones metodológicas.  \n- Evidencia indirecta, es decir, poblaciones o intervenciones que no corresponden exactamente a las preguntas clínicas planteadas.  \n- Falta de estudios bien diseñados y controlados, especialmente ensayos clínicos aleatorizados que permitan comparaciones directas y sólidas entre protocolos de retraso o adelanto de la cirugía.  \n- Heterogeneidad en muestras, diseño de estudios y resultados evaluados.  \n- Escasez o ausencia de datos sobre resultados a largo plazo o en subgrupos específicos como pacientes con pérdida ósea, deformidad o inestabilidad ligamentosa severa.  \n- En ausencia de evidencia publicada, se ha recurrido a la experiencia clínica de los panelistas, considerada como evidencia de muy baja calidad.\n\nEstas limitaciones resultan en recomendaciones condicionales con considerable incertidumbre sobre los efectos de retrasar o adelantar la TJA, enfatizando la necesidad de decisiones personalizadas y compartidas con el paciente.",
        "contexto": [
            "<p>|Recommendation|Certainty of evidence|Based on the evidence report|Page numbers of evidence tables in the Supplementary Appendix†|\n|---|---|---|---|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty 3 months.|Very low|1|1–7|\n|In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for a trial of physical therapy.|Low|2|8–37|",
            "<p>| <strong>Recommendation</strong>                                                                                                 | <strong>Certainty of Evidence</strong> |\n|---------------------------------------------------------------------------------------------------------------------|---------------------------|\n| In our defined population, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty three months. | Very low                 |",
            "to these recommendations, such as a delay for personal reasons due to family or work obligations. It is important that these unique circumstances be considered during the shared decision-making process. The major potential limitation to this guideline is the indirectness and low quality of the available evidence. Moderate-and high-quality studies addressing these PICO questions will be challenging to perform. Direct evidence for our questions would entail randomizing patients indicated for TJA",
            "of bias, imprecision, as well as indirectness. No recommendations were supported by high or moderate quality evidence. There are many existing appropriateness criteria, insurance coverage determination policies, and other guidelines that comment on the indications for elective TJA The Voting Panel recommended against delaying TJA in our defined population for additional nonoperative treatment including physical therapy, NSAIDs, braces or ambulatory aids, as well as intraarticular injections.",
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |"
        ]
    },
    {
        "pregunta": "19. How should patients with bone loss and severe deformity or ligamentous instability be managed concerning timing of TJA?",
        "respuesta": "En pacientes con **pérdida ósea, deformidad severa o inestabilidad ligamentosa grave**, la guía **recomienda de manera condicional proceder a la artroplastia total de articulación (TJA) sin retrasos** para optimizar condiciones no amenazantes para la vida.\n\nLos retrasos en estos casos pueden provocar:\n\n- Aumento de la inestabilidad articular,  \n- Pérdida ósea yuxtaarticular y deformidad progresiva,  \n- Incremento de la dificultad técnica de la cirugía,  \n- Mayor riesgo de fracaso de la prótesis y necesidad de revisiones quirúrgicas posteriores.\n\nAunque estos pacientes tienen un riesgo incrementado de revisión o reoperación, este riesgo **aumenta con el tiempo** si se demora la cirugía. Por ello, se recomienda realizar la TJA de manera oportuna, ya que retrasarla no mejora los resultados posquirúrgicos y complica el procedimiento.  \n\nNo existen estudios directos o indirectos que respondan específicamente a esta pregunta (PICO), por lo que la recomendación se basa en consenso y evidencia muy limitada.\n\nEn resumen, en pacientes con pérdida ósea, deformidad severa o inestabilidad grave, la TJA debe realizarse sin demoras para evitar complicaciones y dificultades técnicas asociadas con el progreso de estas alteraciones estructurales.",
        "contexto": [
            "| In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying arthroplasty for optimization of non-life-threatening conditions. | There were no studies that either directly or indirectly answered our PICO question. |",
            "In these patients, delaying TJA may lead to increased instability and increased juxtaarticular bone loss or deformity, which may increase the technical difficulty of the procedure as well as increase the risk of failure and need for revision. Although patients who have severe bone loss, deformity, or instability have an increased risk of revision or reoperation, this risk will likely only increase over time, with further delay in surgery. Thus, timely TJA should be performed in these cases when",
            "|In our defined population with bone loss with deformity or severe ligamentous instability, we conditionally recommend proceeding to TJA without delay over delaying TJA for optimization of non–life-threatening conditions.|There were no studies that either directly or indirectly answered our PICO question.|12|181|",
            "implants typically reserved for revision arthroplasty. Proceeding with operative treatment in these cases is recommended because delaying surgery increases the technical difficulty of the procedure and does not improve outcomes after the procedure DISCUSSION This guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis who have chosen to undergo",
            "this guideline provides evidence-based recommendations regarding the optimal timing of elective TJA in patients who have symptomatic moderate-to-severe OA or advanced symptomatic ON with secondary arthritis for whom nonoperative treatment has been ineffective and who have chosen to undergo surgical treatment after a shared decision-making process with their physician. Further recommendations regarding the timing of TJA in patients who have specific medical comorbidities and risk factors are"
        ]
    },
    {
        "pregunta": "20. How does the guideline address heterogeneity among populations with OA versus osteonecrosis with secondary arthritis in terms of surgical timing?",
        "respuesta": "La guía aborda la heterogeneidad entre las poblaciones con osteoartritis (OA) y aquellas con osteonecrosis (ON) con artritis secundaria indicando que, aunque estas poblaciones son claramente heterogéneas, no se encontró evidencia de diferencias en los resultados clínicos relacionados con el momento quirúrgico entre una y otra. \n\nPor lo tanto, se trataron **en conjunto** para efectos de las recomendaciones sobre el momento óptimo para la artroplastia total electiva, sin diferenciar el abordaje en función del tipo de patología (OA versus ON) ni la articulación afectada (cadera o rodilla). \n\nEsto implica que las recomendaciones sobre el momento quirúrgico se aplican globalmente a pacientes con OA u ON moderada a severa y síntomas incapacitantes, sin establecer distinciones específicas basadas en la causa subyacente de la artritis.\n\nEn resumen, aunque reconocen la heterogeneidad clínica, la guía no distingue el momento quirúrgico por tipo de patología dada la ausencia de evidencia que respalde diferencias importantes en resultados.",
        "contexto": [
            "that would be included in the literature review, with an understanding that subgroups might be created if evidence of differences in clinical outcomes was found by joint type (hip versus knee) and pathology (OA versus ON with secondary arthritis). No such evidence was found, and therefore, these were treated as a group despite the clear heterogeneity of the populations. Additional cost to the patient and cost effectiveness of nonoperative treatments were considered when the recommendations were",
            "be noted that the evidence and consensus used to inform this guideline were drawn primarily from orthopedic literature. As in the prior version, this guideline does not address indications for THA or TKA, medical decisions unrelated to antirheumatic drug therapy, the choice of the implant, the surgical approach, or the perioperative evaluation and management of concurrent disease, such as that affecting the cervical spine of patients with RA. Although routine perioperative care and preoperative",
            "There were no studies that either directly or indirectly answered our PICO question. 13 181 * The defined population is patients with radiographically moderate-to-severe osteoarthritis or osteonecrosis of the hip or knee using standard radiographic grading such as Kellgren/Lawrence or Tonnis, and for patients with moderate-to-severe pain or loss of function who have been indicated for elective total joint arthroplasty (TJA) through a shared decision-making process with their physician and have",
            "10.1002/acr.25175 Submitted for publication March 10, 2023; accepted in revised form June 14, 2023.  INTRODUCTION Patients who have osteoarthritis (OA) and advanced symptomatic osteonecrosis (ON) with secondary arthritis can benefit from nonoperative treatment, e.g., physical therapy, nonsteroidal antiinflammatory drugs (NSAIDs), braces, intraarticular injections, and weight reduction For this guideline, our population consists of patients who have moderate-to-severe pain and loss of function",
            "2023 American College of Rheumatology and American Association of Hip and Knee Surgeons Clinical Practice Guideline for the Optimal Timing of Elective Hip or Knee Arthroplasty for Patients With Symptomatic Moderate-to-Severe Osteoarthritis or Advanced Symptomatic Osteonecrosis With Secondary Arthritis for Whom Nonoperative Therapy Is Ineffective  American College of Rheumatology      6E2D3A150A173E976859B79AA172C610 10.1002/acr.25175 Submitted for publication March 10, 2023; accepted in"
        ]
    }
]